Biton, V; Werhahn, KJ; Johnson, ME et al.
BRIVARACETAM AS ADJUNCTIVE TREATMENT OF REFRACTORY PARTIAL-ONSET SEIZURES IN ADULTS: RESULTS FROM TWO RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALSEPILEPSIA. Bd. 50. 2009 S. 106-107
Husmann, G
Brustkrebs - Stand der Registrierung in Rheinland-PfalzÄrzteblatt Rheinland-Pfalz. Bd. 06. 2009 S. 17
Kolbe, K; Karstens, A; Krämer, I
Busulfan systemic exposure after oral administration of extemporeanously prepared high-dose busulfan capsulesJ Oncol Pharm Pract. Bd. 16. H. 3. 2009 S. 151-9
Papritz, M; Pohl, C; Wubbeke, C et al.
Cadmium disrupts epithelial barrier of a human alveolar co-culture model from the basal sideNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 379. 2009 S. 70-70
Spallek, J; Arnold, M; Hentschel, S et al.
Cancer incidence rate ratios of Turkish immigrants in Hamburg, Germany: A registry based studyCANCER EPIDEMIOLOGY. Bd. 33. H. 6. 2009 S. 413-418
Spallek, J; Arnold, M; Hentschel, S et al.
Cancer incidence rate ratios of Turkish immigrants in Hamburg, Germany. A registry based studyInt J Cancer. Bd. 33. 2009 S. 413-418
Wiesner, C; Salzer, A; Thomas, C et al.
CANCER SPECIFIC SURVIVAL AFTER RADICAL CYSTECTOMY AND STANDARDIZED EXTENDED LYMPHADENECTOMY FOR N plus BLADDER CANCER: PREDICTION BY OVERALL AND LEVEL SPECIFIC LYMPH NODE DENSITYEUROPEAN UROLOGY SUPPLEMENTS. Bd. 8. H. 4. 2009 S. 286-286
Wiesner, C; Salzer, A; Thomas, C et al.
Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and densityBJU Int. Bd. 104. H. 3. 2009 S. 331-335
Moehler, M; Sprinzl, MF; Abdelfattah, M et al.
Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patientsWorld J Gastroenterol. Bd. 15. H. 4. 2009 S. 449-56
Post, F; Munzel, T
Cardiac emergencies: new solutions for old problemsHERZ. Bd. 34. H. 3. 2009 S. 173-174